Generate a tailored SOP for Dr. Kenneth Man. Improve your application with a focused, well-structured draft.
Kenneth Man is a pharmacoepidemiologist and medical statistician specializing in the use of electronic health records and big data to address critical questions regarding medication safety and effectiveness. His work incorporates advanced methodologies, including propensity scores, self-controlled designs, and target trial emulation, to generate real-world evidence that informs healthcare practices worldwide. His research primarily focuses on psychotropic medications and their use in children, adolescents, and during pregnancy. He has authored 160 studies featured in prestigious journals such as Nature Medicine, BMJ, and JAMA, and his work is referenced by regulatory bodies and clinical guidelines globally. Kenneth has received numerous prestigious awards, including the Kramer-Pollnow Prize for excellence in ADHD research and funding from the CW Maplethorpe Fellowship and the European Commission Horizon 2020 Framework. He has held academic research roles at the University of Hong Kong and Erasmus University Medical Center, and collaborates with international research networks to develop common data models in Asia. His current projects address urgent public health issues such as medication shortages, safety of prenatal drug exposure, and optimizing ADHD treatment pathways.
University College London • United Kingdom
Lecturer in the Department of Practice and Policy.
UCL School of Pharmacy • United Kingdom
Fellow focusing on research in the Department of Practice and Policy.
Central Advisory Committee (CAC) • London, United Kingdom
Member of the Clinical Practice Research Datalink.